
Synergy Shield Coronary Stent 2.25 X 8 | REF H7493966608220
Boston Scientific Synergy Shield Coronary Stent, 2.25 mm x 8 mm, REF H7493966608220. Single-unit B2B catalog listing for hospital and cath lab procurement.

The Terumo Ultimaster Nagomi Coronary Stent (REF DE-RS2709ASM) is a sirolimus-eluting coronary stent system pre-mounted on a rapid-exchange delivery catheter, configured at 2.75 mm diameter × 9 mm length. It is engineered for percutaneous coronary intervention with a focus on deliverability, conformability and a bioresorbable abluminal polymer drug-coating concept.
Key Features
Cobalt-chromium thin-strut stent platform designed for low crossing profile and flexibility.
Abluminal-only bioresorbable PDLLA-PCL polymer coating intended to release sirolimus and resorb over time.
Sirolimus as the active pharmaceutical agent.
Rapid-exchange (monorail) delivery system with low-profile balloon for navigation through tortuous anatomy.
Pre-mounted, sterile, single-use configuration with radiopaque balloon markers.
Size in this reference: 2.75 mm × 9 mm.
Clinical Applications
Indicated by the manufacturer for use in percutaneous coronary intervention procedures targeting de novo coronary artery lesions, in line with the official Instructions for Use. Refer to the current Terumo IFU for full indications, contraindications, warnings, target vessel reference diameter range and approved patient population in the destination market.
Product Information
Brand: Terumo
Product line: Ultimaster Nagomi
Category: Coronary Stents (Drug-Eluting)
REF / UPN: DE-RS2709ASM
Stent diameter: 2.75 mm
Stent length: 9 mm
Drug: Sirolimus
Polymer: Bioresorbable abluminal PDLLA-PCL
Delivery system: Rapid exchange
Guidewire compatibility: Not specified in the located sources
Guide catheter compatibility: Not specified in the located sources
Nominal / RBP pressure: Not specified in the located sources
Sterility: Sterile, single use
Regulatory status: Refer to local Terumo representative and current IFU for market-specific clearance.
Practical answers for procurement teams reviewing this product page.
Include the exact product family, brand preference, REF/UPN code when available, required quantity, destination country, expected delivery timing and documentation expectations.
Yes. If alternatives are acceptable, mention equivalent brands, compatible models, size ranges and any non-negotiable requirements.
Related products are connected through structured catalog data such as brand, category, product family and country assignment.
No. This page supports sourcing and RFQ organization. Buyers must verify regulatory status, clinical suitability and procurement compliance independently.
Specific codes reduce ambiguity and help supplier teams identify product availability, packaging details and documentation faster.
Yes. The workflow is designed for hospitals, clinics, distributors, wholesalers, importers and procurement departments.
Yes. Products can be connected to multiple countries in the admin panel, and buyers can specify destination details in the RFQ form.
The request is stored with contact and procurement details so the sourcing conversation can be reviewed and followed up clearly.